Skip to main content
ConductScienceScienceDex

Matthew Robert Lewin

NIH Rank #14794
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8501210Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$1.1M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#14,794
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Matthew Robert Lewin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Matthew Robert Lewin as a PI. Multi-PI records show the full award amount for context.

  • 5R01FD007839-03R01
    Development of Intravenous Varespladib, a Phospholipase A2 Inhibitor, for the Treatment of Snakebite Envenoming
    Ophirex, Inc.
    $1.1M
    award amount

Award organization

Organizations that administered FY2025 awards listing Matthew Robert Lewin as a PI.

FY2025 award administered by Ophirex, Inc. (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Ophirex, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    R01 Grant Holder
  4. 2025
    $1M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Matthew Robert Lewin.

Rebecca Wonder Carter
Ophirex, Inc.
2
shared awards
Tim Platts-mills
Ophirex, Inc.
2
shared awards

Explore further

Find collaborators for Matthew Robert Lewin

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →